نتایج جستجو برای: candida azole resistance

تعداد نتایج: 403294  

Journal: :Antimicrobial agents and chemotherapy 2008
Scott E Gygax John-Paul Vermitsky Sean G Chadwick Matthew J Self Jessica A Zimmerman Eli Mordechai Martin E Adelson Jason P Trama

A multiplex quantitative reverse transcription-PCR assay was developed to detect azole resistance in Candida glabrata, an important opportunistic pathogen that develops resistance rapidly. Resistance was defined as a >or=3-fold increase in CDR1 expression by this assay, which proved to be 100% sensitive and 95% specific in comparison to the gold standard broth microdilution assay.

Journal: :The Journal of antimicrobial chemotherapy 2013
Cen Jiang Danfeng Dong Beiqin Yu Gang Cai Xuefeng Wang Yuhua Ji Yibing Peng

OBJECTIVES To explore the mechanisms underlying azole resistance in clinical isolates of Candida tropicalis collected in China by focusing on their efflux pumps, respiratory status and azole antifungal target enzyme. METHODS Fifty-two clinical isolates of C. tropicalis were collected from five hospitals in four provinces of China and antifungal susceptibility tests were performed. Rhodamine 6...

Journal: :Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2016
S Imbert L Castain A Pons S Jacob I Meyer M Palous C Vezinet O Langeron C Hennequin A Monsel A Fekkar

To give an indication of a fitness cost conferred by FKS mutation-associated echinocandin resistance in Candida glabrata during human infection. Six C. glabrata clinical strains sequentially isolated from blood and a hepatic abscess in a solid organ transplant recipient were analysed. The patient had received long-term azole and echinocandin therapy for invasive aspergillosis and persistent can...

2010
Bryce E. Mansfield Hanna N. Oltean Brian G. Oliver Samantha J. Hoot Sarah E. Leyde Lizbeth Hedstrom Theodore C. White

Despite the wealth of knowledge regarding the mechanisms of action and the mechanisms of resistance to azole antifungals, very little is known about how the azoles are imported into pathogenic fungal cells. Here the in-vitro accumulation and import of Fluconazole (FLC) was examined in the pathogenic fungus, Candida albicans. In energized cells, FLC accumulation correlates inversely with express...

2013
Min Joong Jang Jong Hee Shin Wee Gyo Lee Mi-Na Kim Kyungwon Lee Hye Soo Lee Mi-Kyung Lee Chulhun L. Chang Hee-Chang Jang Eun Song Song Soo Hyun Kim Myung-Geun Shin Soon-Pal Suh Dong-Wook Ryang

BACKGROUND At present, the clinical breakpoints (CBPs) of both fluconazole and voriconazole are available only for 3 common Candida species in the Clinical and Laboratory Standards Institute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST) methods. Epidemiological cutoff values (ECVs) were recently applied to both methods to detect the emergence of acquired res...

Journal: :PLoS Pathogens 2009
Sélène Ferrari Françoise Ischer David Calabrese Brunella Posteraro Maurizio Sanguinetti Giovanni Fadda Bettina Rohde Christopher Bauser Oliver Bader Dominique Sanglard

CgPdr1p is a Candida glabrata Zn(2)-Cys(6) transcription factor involved in the regulation of the ABC-transporter genes CgCDR1, CgCDR2, and CgSNQ2, which are mediators of azole resistance. Single-point mutations in CgPDR1 are known to increase the expression of at least CgCDR1 and CgCDR2 and thus to contribute to azole resistance of clinical isolates. In this study, we investigated the incidenc...

2017
Cecylia Łukaszuk Elżbieta Krajewska-Kułak Wojciech Kułak

INTRODUCTION There is much literature devoted to the problem of drug resistance and decreased susceptibility of fungi to commonly used antifungals. AIM To analyze drug susceptibility of Candida albicans and non-Candida albicans strains isolated from the hands of people without any symptoms of disease over a 16-year period. MATERIALS AND METHODS The study included a total of 1,274 Candida-ty...

2017
Matthew Z. Anderson Amrita Saha Abid Haseeb Richard J. Bennett

Candida albicans is an important opportunistic fungal pathogen capable of causing both mucosal and disseminated disease. Infections are often treated with fluconazole, a front-line antifungal drug that targets the biosynthesis of ergosterol, a major component of the fungal cell membrane. Resistance to fluconazole can arise through a variety of mechanisms, including gain-of-function mutations, l...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید